Electroconvulsive Therapy and the Push for Personalized Approaches in Psychiatry
Electroconvulsive therapy, commonly abbreviated as ECT, remains one of the most effective interventions for severe major depressive disorder, or MDD. Despite its established role, researchers continue to refine understanding of factors that influence individual outcomes. A new study published in the Journal of Affective Disorders examines how biological sex interacts with clinical predictors to shape remission rates following ECT.
The research draws on data from the Dutch ECT Consortium, known as DEC, a collaborative network of depression researchers across multiple Dutch clinical and academic sites. This consortium aggregates real-world clinical information to support evidence-based improvements in treatment protocols.
The Dutch ECT Consortium and Its Growing Body of Work
The Dutch ECT Consortium brings together clinicians and investigators from twelve sites to collect standardized data on ECT procedures and patient responses. Earlier consortium projects have produced prediction models for treatment effectiveness and examined cognitive side effects. The current analysis extends that foundation by focusing explicitly on sex as a moderating variable.
By pooling records from 22 cohorts, the consortium enables large-scale analyses that single-center studies cannot achieve. This approach supports replication and helps identify patterns that may inform guidelines for more tailored care.
Study Methods and Participant Characteristics
Investigators analyzed clinical data from 1892 adults diagnosed with major depressive disorder who received ECT. Women comprised 1210 of the participants, reflecting typical sex distributions in treatment-seeking populations for depression. The average age across the sample was 59.5 years.
Remission was defined rigorously as a post-treatment score of 7 or lower on the Hamilton Depression Rating Scale, often referred to as HDRS. Clinical variables were selected based on prior literature, including duration of the index depressive episode and history of psychotherapy during the current episode. Statistical models tested for interactions between these variables and patient sex.
Overall Effectiveness Shows No Sex-Based Difference
The study found no statistically significant difference in remission rates between women and men. The chi-square test yielded a value of 2.0 with a p-value of 0.17, indicating comparable overall success of ECT across sexes. This result aligns with the broader evidence that ECT functions as a robust biological treatment irrespective of sex.
Clinicians can therefore continue to recommend ECT confidently for eligible patients of either sex when other criteria are met. The absence of a main effect for sex underscores the therapy's broad applicability while leaving room for examination of more subtle moderating influences.
Interaction Effect: Duration of Depressive Episode
A significant sex-by-episode-duration interaction emerged, with a chi-square value of 4.36 and p-value of 0.04. For men, longer duration of the current depressive episode was associated with declining likelihood of remission after ECT. Women's remission rates, by contrast, remained relatively stable regardless of how long the episode had lasted.
This pattern suggests that timing of intervention may carry different weight depending on sex. Men experiencing prolonged episodes might benefit from earlier consideration of ECT within their treatment sequence, whereas the data indicate less sensitivity to episode length among women in this cohort.
Photo by National Cancer Institute on Unsplash
Interaction Effect: Prior Psychotherapy Experience
Another notable interaction involved prior evidence-based psychotherapy during the current episode, producing a chi-square of 4.56 and p-value of 0.03. Women who had received such psychotherapy showed lower remission rates compared with men in the same category.
The finding is described as tentative and modest in magnitude. It does not imply that psychotherapy reduces ECT efficacy overall; rather, it highlights a potential sex-specific association worth monitoring in clinical decision-making. Further research will be needed to clarify mechanisms and determine whether this pattern replicates in independent samples.
Clinical Implications and the Move Toward Precision Psychiatry
The authors emphasize that ECT delivers equivalent effectiveness for women and men. At the same time, they note that awareness of modest sex-related patterns can support more individualized conversations between clinicians and patients. Factors such as episode duration and treatment history may warrant additional attention when planning care.
Understanding potential sex differences in both efficacy signals and side-effect profiles contributes to the broader goal of precision medicine in psychiatry. The study encourages clinicians to integrate these nuances without overinterpreting small interaction effects.
Context Within Ongoing Research on Sex Differences
This DEC analysis builds on earlier work, including a 2023 study from the Global ECT-MRI Research Collaboration that similarly reported comparable remission rates across sexes while identifying some sex-specific predictors. Such cumulative evidence strengthens confidence in ECT as a sex-neutral intervention at the population level.
The Dutch consortium's open-access approach facilitates wider scrutiny and secondary analyses. Data requests for academic purposes can be directed through the consortium board, subject to applicable privacy regulations.
Future Research Directions and Training Implications
Larger, prospective studies could test whether the observed interactions hold across diverse populations and treatment settings. Integration of additional variables, such as hormonal status or genetic markers, may further refine predictive models.
For academic departments and training programs in psychiatry and clinical psychology, these findings underscore the value of incorporating sex-stratified analyses into research curricula. Trainees benefit from exposure to large collaborative datasets and modern statistical approaches to interaction testing.
Accessing the Full Publication
The complete study, titled "Impact of sex differences on the association between clinical predictors and electroconvulsive therapy outcomes: results from the Dutch ECT Consortium (DEC)," appears in the Journal of Affective Disorders and is available open access under a Creative Commons license. The full author list includes Machteld A.J.T. Blanken, Mardien L. Oudega, Dore Loef, Patrick F.A. Tuijp, E. van Exel, Metten Somers, Edwin van Dellen, Roel J.T. Mocking, Dominika Karaszewska, Anouk E. de Wit, Johanna M. Hegeman, Karen van den Berg, Didi Rhebergen, Bart P.F. Rutten, Birit F.P. Broekman, Anton C.M. Vergouwen, Thomas J.C. Zoon, Rob M. Kok, Karina Somers, Esmée Verwijk, and Annemiek Dols.
Readers can review the publication directly at the ScienceDirect page. Additional resources on consortium activities are hosted at the Dutch ECT Consortium website.
Broader Impact on Academic Mental Health Research
Collaborative efforts like the Dutch ECT Consortium illustrate how multi-site data sharing accelerates progress in understanding treatment heterogeneity. Universities and research institutes benefit from participation in such networks through shared publications, grant opportunities, and training pipelines for the next generation of clinician-scientists.
As precision approaches gain traction, studies that systematically examine demographic moderators such as sex contribute essential building blocks for updated clinical guidelines and educational materials.
